Melanoma Reagents | abinScience

Home > Featured Products > Oncology Research > Melanoma

960 product results for "Melanoma"

Options+

Options

Confirm

Product types

0 selected

Antibodies (298)

Stable Cell Lines (1)

Assay Kit (419)

Proteins (75)

Biosimilars (1)

Research Biosimilar (157)
Expression system

0 selected

Mammalian Cells (186)

HEK293T (1)

E. coli (35)
Target

0 selected

PMEL17/ME20M (9)

Protein A (1)

Tisotumab (1)

RBD (Kappa) (1)

Ramucirumab (1)

Nesvacumab (1)

Pembrolizumab (3)

mitF/aspF1 (1)

Milatuzumab (1)

Avelumab (3)

Befovacimab (1)

Casirivimab (1)

Bimagrumab (1)

gC/Envelope glycoprotein C (1)

Utomilumab (1)

Gevokizumab (1)

Tezepelumab (1)

Teprotumumab (1)

IL6 (1)

Bevacizumab (3)

SARS-CoV-2 Neutralization Antibody (3)

Ivuxolimab (1)

PDL1 & VEGF (1)

Panitumumab (3)

Ixekizumab (1)

Siltuximab (3)

Suvizumab (1)

CD47/MER6 & PDCD1 / PD-1 & CD137/4-1BB/TNFRSF9 (1)

Ibritumomab (1)

RBD (Omicron/BA.4/BA.5) (1)

CD278/ICOS (1)

Itolizumab (1)

TPP15 (1)

Anetumab (1)

Zanolimumab (1)

Blosozumab (1)

Lacnotuzumab (1)

Iscalimab (1)

Olaratumab (1)

Glycoprotein (5)

S100A9 (4)

Asp f 1/mitF (1)

CD274/PD-L1 & CD134/OX40 (1)

CD274/PD-L1 & CD28 & CD152/CTLA4 (1)

CD47/MER6 & CD274/PD-L1 (2)

S100A16 (1)

HLA-A2-peptide (TDQVPFSV) Complex (1)

Ieramilimab (1)

CD274/PD-L1 & VEGFA (1)

TYRP1 (3)

CD19 & PD-L1 & CD3E & CD137 (1)

Tovetumab (1)

M/Matrix protein (2)

CD3E (1)

Belantamab (1)

PD-L1 / VEGF-A (1)

Certolizumab (2)

Enoblituzumab (1)

Cabiralizumab (1)

Gremubamab (1)

Human β Amyloid (1-42) (1)

RBD (Delta Plus) (1)

Spike glycoprotein (RBD) (1)

Vanucizumab (1)

Sintilimab (1)

Glycoprotein G (2)

Durvalumab (3)

CD80&IL2 (1)

Concizumab (1)

Imdevimab (1)

CD117/KIT (24)

Rolinsatamab (1)

gC/UL44 (1)

Magrolimab (1)

CD20/MS4A1 (3)

Etanercept (3)

Brolucizumab (1)

RBD (Omicron/BA.5) (3)

Pogalizumab (1)

Serclutamab (1)

Remtolumab (1)

Clazakizumab (1)

Mosunetuzumab (1)

TPP17 (1)

Conatumumab (1)

Romosozumab (1)

TYR (1)

Romiplostim (2)

CD274/PD-L1 & CD279/PD-1 (1)

Oleclumab (1)

IDO1 (2)

CD366/TIM-3 & CD279/PD-1 (2)

Sarilumab (2)

CD152/CTLA4 & CD279/PD-1 (1)

HLA-A2-peptide (ITDQVPFSV) Complex (4)

EGFR & CD3E & PD-L1 & 4-1BB (1)

CD366/TIM-3 & CD274/PD-L1 (1)

TRP-1 & CD47/MER6 (1)

Sacituzumab (1)

Eculizumab (3)

Varlilumab (1)

Tirzepatide (2)

gp100 peptide-HLA Complex (1)

Teclistamab (1)

Mirzotamab (1)

CD223 (1)

Emactuzumab (1)

M1R (5)

Human β Amyloid (1-40) (1)

Imalumab (1)

Semaglutide (2)

Ascrinvacumab (1)

TFF3 (1)

Tislelizumab (1)

Disitamab (1)

Pacmilimab (1)

TDP2 (1)

Marstacimab (1)

Daratumumab (3)

gD/US6 (1)

Basiliximab (1)

Elezanumab (1)

Apamistamab (1)

Ranibizumab (3)

NP/Nucleoprotein (3)

Tavolimab (1)

Secukinumab (2)

Imlifidase (5)

Olokizumab (1)

Foravirumab (1)

CD47/MER6 & CD274/PD-L1/B7-H1 (2)

Ocaratuzumab (1)

Elotuzumab (1)

Cusatuzumab (1)

TPP47 (1)

Drozitumab (1)

Ontamalimab (1)

Eldelumab (1)

CD274/PD-L1 & TGFBR2/TGFR-2 (1)

CD80/B7-1 & CD86/B7-2 (2)

S100A11 (2)

HLA-A2-peptide (YLEPGPVT) Complex (4)

Calprotectin (S100A8/9) (3)

BRAF/B-Raf (5)

Mavezelimab (1)

CD137/4-1BB & CD274/PD-L1 (3)

TRP-1 & CD134/OX40 (1)

Mirikizumab (2)

PDL1 (6)

Aflibercept (1)

Ipilimumab (2)

GP/Envelope glycoprotein (4)

T3E (1)

Golimumab (3)

Omburtamab (1)

TAU pT181 (1)

Evolocumab (1)

EPO/Erythropoietin (1)

Lupartumab (1)

Toripalimab (1)

Exenatide acetate (2)

Pertuzumab (3)

CD137/4-1BB/TNFRSF9& CD274/PD-L1/B7-H1 (1)

Denosumab (3)

US8/gE (1)

Sibrotuzumab (1)

Fluorescein & CD274/PD-L1 (1)

Camidanlumab (1)

Mazdutide (2)

RBD (6)

Varisacumab (1)

RBD (Omicron/JN.1) (1)

Lirilumab (1)

CTLA4 & PD1 (2)

Tesidolumab (1)

Sirukumab (1)

Rafivirumab (1)

cAMP (1)

RBD (WT) (1)

Vorsetuzumab (1)

G/Major surface glycoprotein G (1)

Lexatumumab (1)

CD86/B7-2 (26)

CD152/CTLA4 & CD274/PD-L1 (1)

Zampilimab (1)

NRAS (2)

CD175/Tn (10)

S100A6 (1)

Omalizumab (2)

HLA-A2-peptide (KTWGQYWQV) Complex (2)

Favezelimab (1)

Tigatuzumab (1)

Glembatumumab (1)

Lenzilumab (1)

Semorinemab (1)

Talacotuzumab (1)

S100A5 (4)

Tremelimumab (1)

gG/US4 (2)

T-cell surface antigen T3/Leu-4 epsilon chain (1)

Pasotuxizumab (1)

TIGIT & CD274/PD-L1 (1)

Cixutumumab (1)

H3L (3)

TAU pT217 (1)

Andecaliximab (1)

Alirocumab (1)

Cinpanemab (1)

CD274/PD-L1 & CD28 (1)

TYR/Tyrosinase (2)

Trastuzumab (2)

Nirsevimab (1)

CD47/MER6 & PDCD1 / PD-1 / CD279 (1)

Obinutuzumab (2)

Cetuximab (3)

Ifabotuzumab (1)

CD366/HAVCR2/TIM-3 (4)

Spike glycoprotein E2 (2)

Simlukafusp Alfa (1)

LAG3 & PD-1 (1)

Daclizumab (1)

Enfortumab (1)

Emibetuzumab (1)

RBD (Delta) (3)

FLT1/VEGFR1 & CD274/PD-L1 (1)

RBD (Omicron/KP.2) (1)

Tibulizumab (1)

Ziltivekimab (1)

VASH2/Vasohibin-2 (1)

Carlumab (1)

RBD (Alpha) (1)

N/Nucleoprotein (1)

S100A14 (1)

CD274/PD-L1 (81)

Anifrolumab (1)

S100a15a (1)

CD152/CTLA4 & CD134/OX40 (1)

Rituximab (1)

CD274/PD-L1 & CD137/TNFRSF9 (1)

S100A12 (1)

Meplazumab (1)

Balstilimab (1)

Namilumab (1)

Dilpacimab (1)

Tilavonemab (1)

Natalizumab (2)

S100A8 (3)

Vibecotamab (1)

Zalifrelimab (1)

gB/Envelope glycoprotein B (1)

T-cell surface glycoprotein CD3 epsilon chain (1)

Rosopatamab (2)

Infliximab (2)

Frovocimab (1)

Dalotuzumab (1)

E8L (5)

S100A2 (1)

Depatuxizumab (1)

Retatrutide (1)

Zanidatamab (1)

Palivizumab (3)

KITLG/SCF (1)

Afutuzumab (1)

sCD14 (1)

CD366/TIM-3 (34)

Spike glycoprotein E1 (2)

Spike glycoprotein (10)

Crizanlizumab (1)

CD340/ERBB2 (1)

Codrituzumab (1)

Tanezumab (1)

Vunakizumab (1)

Tosatoxumab (1)

SOX10 (3)

RBD (Beta) (1)

Indatuximab (1)

S100B (9)

CD223/LAG3 (41)

CD279/PD-1 & CD274/PD-L1 (1)

CD137/4-1BB & CD274/PD-L1 & ROR1 & CD3 (1)

S100A1 (2)

Vofatamab (1)

CD223/LAG3 & CD279/PD-1 (4)

Abatacept (1)

S100A13 (1)

S100A4 (3)

CD274/PD-L1 & CD152/CTLA4 (1)

cGMP (1)

Lorvotuzumab (1)

RBD (Gamma) (1)

MITF (1)

Cetrelimab (1)

DCT (2)

Otilimab (1)

Navicixizumab (1)

VEGFA & B7-H1 / PD-L1 / CD274 (1)

Zagotenemab (1)

gE/Envelope glycoprotein E (1)

Tarextumab (1)

Lodelcizumab (1)

PD-L1 & VEGF (1)

Figitumumab (1)

A35R (5)

Farletuzumab (1)

Ustekinumab (3)

CD79B (2)

Losatuxizumab (1)

Afasevikumab (1)

β-D-Glucan (1)

Suptavumab (1)

B7-H1 / PD-L1 / CD274 & CD3E (1)

Epcoritamab (1)

F/Fusion glycoprotein F0 (5)

Letolizumab (1)

dsRNA (1)

Ibalizumab (1)

Ianalumab (1)

Tocilizumab (3)

Spike Protein (Trimer) (2)

Dupilumab (3)

Inclacumab (1)

IL1RL1/ST2 (1)

VSIR/VISTA & CD274/PD-L1 (1)

Cergutuzumab (1)

CD279/PD-1 & CD152/CTLA4 (4)

CD274/PD-L1 & CD3E (1)

p-Tyr (1)

Icrucumab (1)

CD152/CTLA4 (86)

CD274/PD-L1 & TGFBR2 (1)

Labetuzumab (1)

Obiltoxaximab (1)

BSA (1)

RBD (E484K) (1)

Alacizumab (1)

Faricimab (1)

Nivolumab (3)

Atezolizumab (3)

Sotrovimab (1)

MLANA (4)

Edrecolomab (1)

gD/Envelope glycoprotein D (1)

Urelumab (1)

Canakinumab (1)

LAG-3 & PD-1 (1)

Ganitumab (1)

A29L (6)

Mirvetuximab (1)

B6R/SL-159 (1)

CD274/PD-L1/B7-H1 (5)

Necitumumab (1)

Bimekizumab (1)

Zenocutuzumab (1)

Glofitamab (1)

Guselkumab (3)

ATP7B (1)

Benufutamab (1)

Amatuximab (1)

Tregalizumab (1)

PD-L1 & TGF-Beta (1)

NP/Nucleocapsid (5)

dsDNA (1)

Astegolimab (1)

Adalimumab (3)

Tiragolumab (2)

CD223/LAG3 & CD152/CTLA4 (1)

S100A10 (4)

Lintuzumab (1)

CD274/PD-L1 & CD47/MER6 (1)

CD274/PD-L1 & SLT-Ia (1)

CD80/B7-1 (20)

Oxelumab (1)

TRP-1 & CD3e (1)

S100P (1)
Species

0 selected

Cat (1)

Mouse (27)

Rat (1)

Neosartorya fumigata (1)

Canis lupus familiaris (1)

Mus musculus (Mouse) (7)

Tupaia chinensis (12)

Homo sapiens (Human) (7)

Canis lupus familiaris (Dog) (8)

Dog (3)

Human (178)

Felis catus (Cat) (9)
Applications

0 selected

Bioactivity: FACS (1)

Functional assay (158)

in vitro PD-L1 blockade (3)

SDS-PAGE (75)

Research in vivo (158)

IHC-F (3)

FACS (5)

Immunogen (75)

IF (8)

Research in vivo (4)

Functional assay (6)

Bioactivity testing in progress (31)

Blocking (2)

Neutralization (2)

ELISA (844)

in vivo CTLA-4 neutralization (2)

GICA (2)

in vivo blockade (2)

Neut (1)

FCM (152)

IHC (84)

in vivo (2)

in vivo intra-tumoral regulatory T cell depletion (2)

FuncS (18)

Inhib (1)

WB (165)

IFA (4)

Bioactivity: FACS (153)

in vivo PD-L1 blockade (3)

SPR (4)

IP (2)
Reactivity

0 selected

Xenopus laevis (1)

Macaca mulatta (1)

Drosophila grimshawi (1)

Broad-Spectrum (1)

Rat (16)

Bovine (1)

Neosartorya fumigata (1)

Drosophila willistoni (1)

Homo sapiens (Human) (4)

Monkey (5)

Cat (1)

Kirsten murine sarcoma virus (1)

Kryptolebias marmoratus (1)

Avian retrovirus IC10 (1)

Carassius auratus (1)

Chicken (4)

Limanda limanda (1)

Avian rous-associated virus type 1 (1)

Tupaia chinensis (4)

Cavia porcellus (1)

Pig (6)

Mesocricetus auratus (1)

Bos taurus (8)

Coturnix japonica (1)

Mouse (77)

Cynomolgus monkey (1)

Dog (13)

Human (198)

Pongo abelii (2)

Cyprinus carpio (1)

Callithrix jacchus (1)

Monodelphis domestica (1)

Oryctolagus cuniculus (4)

Rhesus macaque (1)

Mus musculus (Mouse) (1)

B7-H1 / PD-L1 / CD274 (1)

Danio rerio (1)

Capra hircus (1)

Oryzias latipes (1)
Host species

0 selected

Chimeric (5)

Rat (14)

Humanized (34)

Alpaca (6)

HEK293T (1)

Human (157)

Dog (2)

Mouse (164)

Armenian Hamster (5)

Rabbit (61)
Clonality

0 selected

Polyclonal (53)

Monoclonal (398)
Conjugate

0 selected

FITC (28)

APC (28)

PerCP (28)

Unconjugated (301)

PE (28)

Recombinant Proteins

Antibodies

Assay Kits

960 product results for "Melanoma"

Varisacumab ELISA Kit (DB941048)

Sample type

Sensitivity

Range

Crizanlizumab ELISA Kit (DB885018)

Sample type

Sensitivity

Range

Tovetumab ELISA Kit (DB927028)

Sample type

Sensitivity

Range

Ipilimumab ELISA Kit (DB651018)

Sample type

Sensitivity

Range

Tremelimumab ELISA Kit (DB651028)

Sample type

Sensitivity

Range

Zalifrelimab ELISA Kit (DB651038)

Sample type

Sensitivity

Range

Edrecolomab ELISA Kit (DB104018)

Sample type

Sensitivity

Range

Rolinsatamab ELISA Kit (DB801018)

Sample type

Sensitivity

Range

Anifrolumab ELISA Kit (DB823018)

Sample type

Sensitivity

Range

Icrucumab ELISA Kit (DB265018)

Sample type

Sensitivity

Range

Quick access

Contact Us